Apply This IPO

Best Margin

Zero Brokerage

24*7 Customer Support.

Fastest mobile support

---

Apply with Angel One

Apply with Zerodha

Pre-Apply with Upstox

Valiant Laboratories Limited IPO Review

Valiant Laboratories Limited was engaged in a company that makes the main ingredients in medicines, particularly focusing on producing Paracetamol. These ingredients, known as Active Pharmaceutical Ingredients (API), are the raw materials used to create finished medicines. Paracetamol, also called Acetaminophen or para-hydroxyacetanilide (C8H9NO2), is a widely used pain reliever recommended as the go-to treatment for pain by the World Health Organization (WHO). 

Paracetamol is used for different things like easing headaches, muscle aches, arthritis, backaches, toothaches, and also for treating colds and fevers. They make Paracetamol in different grades, following the specific standards (IP/BP/EP/USP) required by their customers in the pharmaceutical industry.

Valiant Laboratories Limited Products and Services

 Valiant Laboratories Limited is a top company that makes the main ingredients in medicines, particularly focusing on producing Paracetamol. This ingredient is used for various purposes, including treating headaches, muscle aches, arthritis, backaches, toothaches, and colds and fevers. Their manufacturing facility is located in the Tarapur industrial estate, and they operate from this single location.

The company has a special team focused on doing different research and development projects. Their goal is to find new molecules that the company can turn into products and contribute to its growth. Their leaders have shown that they're really good at building and bringing together different parts of their business. Over the years, they've used their combined experience to make their company grow naturally, make people recognize and trust their brand, and find new chances for their business to succeed.

Financial Overview

The company mainly makes active ingredients for medicines, especially focusing on popular paracetamol. Unfortunately, the profits and margins have been going down in recent times. Looking at the earnings in the fiscal year 2023, it seems like the stock is already valued appropriately. If you're thinking about investing, it might be a good idea to consider it for the medium to long term.